After CFPAC-1 tumor formation, we treated mice with the same conditions as in the xenograft models: 1 × 107 vp CAdTrio and 1 × 106 autologous HER2.CARTs infused three days later (Fig. 4a). Here, ERBB2 is linked to neoplasm.